For the treatment of subclinical mastitis caused by susceptible strains of Staphylococcus aureus and Streptococcus agalactiae in dry cows
Provides synergistic antibiotic combination of penicillin and novobiocin
Bactericidal activity against major Staphylococcus and Streptococcus mastitis pathogens
Ideal duration of activity during the involution phase of the dry cow period, when the keratin plug has not formed and the cow is susceptible to infections
Contents of 1 syringe are infused into each quarter at dry-off
72-hour milk withhold following calving
30-day pre-slaughter withdrawal required following administration